search
Back to results

Aeration, Breathing, Clamping Study 3 (ABC3)

Primary Purpose

Preterm Infant, Birth, Preterm

Status
Active
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Physiological-based cord clamping
Time-based cord clamping
Sponsored by
Leiden University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Preterm Infant focused on measuring Preterm infant, Cord clamping, Resuscitation

Eligibility Criteria

undefined - 29 Weeks (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Infants born at a gestational age below 30 weeks in a participating centre.
  • Parental consent (see 9.2).

Exclusion Criteria:

A potential subject who meets any of the following criteria will be excluded from participation in this study:

  • Significant congenital malformations influencing cardiopulmonary transition.
  • Signs of acute placental abruption.
  • Anterior placenta praevia or invasive placentation (accreta/percreta).
  • Birth by emergency caesarean section (ordered to be executed within 15 minutes).
  • Maternal general anaesthesia during caesarean section.
  • Twin gestation with signs of Twin Transfusion Syndrome or Twin Anaemia Polycythemia Syndrome not treated with fetoscopic laser treatment.
  • Multiple pregnancy > 2 (triplets or higher order).
  • Decision documented to give palliative neonatal care.

In case of twin delivery by caesarean section it is not possible to perform PBCC in both infants. Both infants will be included: the first infant will receive standard treatment and the second infant will be randomised to either PBCC or standard treatment.

Sites / Locations

  • Amsterdam University Medical Centre, location AMC
  • Amsterdam University Medical Centre, location VU
  • University Medical Centre Groningen
  • Leiden University Medical Centre
  • Maastricht University Medical Centre
  • Radboud University Medical Centre
  • Erasmus Medical Centre - Sophia Children's Hospital
  • University Medical Centre Utrecht
  • Maxima Medical Centre
  • Isala Clinics Zwolle

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Physiological-based cord clamping

Time-based cord clamping

Arm Description

Stabilisation of the infant is performed while the cord is intact and the cord will be clamped after the infant is cardiopulmonary stable. Stable is defined as the establishment of heart rate greater than 100 bpm and oxygen saturation above 85% while using supplemental oxygen lower than 40%. The maximum cord clamping time is 10 minutes and prior to cord clamping a trial of weaning from PPV to CPAP is performed. With the exception that the infant is stabilised close to the mother and the cord is clamped later, the infant will receive standard resuscitation interventions.

Infants are clamped first and then moved to the standard resuscitation table for further treatment and intervention needed for cardiopulmonary stabilisation. Clamping is time based and performed immediately or delayed at 30-60 seconds, depending on the clinical condition of the infant. Uterotonic drugs are administered immediately after cord clamping.

Outcomes

Primary Outcome Measures

Intact survival at NICU discharge
Intact survival is defined as survival without major cerebral injury (IVH ≥ grade 2 and/or PVL ≥ grade 2 and/or periventricular venous infarction) and/or NEC ≥ Bell stage 2.

Secondary Outcome Measures

Rate of treatment failure
Treatment failure defined as the number of participants in which abortion of prescribed procedure (intervention or control) occurred and the reasons for abortion.
Short-term neonatal outcomes
Incidence of prematurity related morbidities during hospital stay.
Short-term maternal outcomes
Incidence of postpartum haemorrhage (> 1000 ml) and surgical site infection after caesarean section.
Neurodevelopmental outcome (Cognitive) at 2 years corrected age
Neurodevelopmental outcome assessed at 2 years corrected age by the standardized Bayley Scales of Infant Development III (BSID-III-NL), resulting in the Mental Developmental Index. A score of less than 85 (1 SD below the mean of 100) is considered as delayed development.
Neurodevelopmental outcome (Motor) at 2 years corrected age
Neurodevelopmental outcome assessed at 2 years corrected age by the standardized Bayley Scales of Infant Development III (BSID-III-NL), resulting in the Performance Developmental Index. A score of less than 85 (1 SD below the mean of 100) is considered as delayed development.
Functional outcome at 2 years corrected age
The proportion of participants with cerebral palsy, the proportion of participants with hearing loss requiring hearing aids and the proportion of participants with blindness.

Full Information

First Posted
January 1, 2019
Last Updated
May 9, 2023
Sponsor
Leiden University Medical Center
Collaborators
Erasmus Medical Center, Medical Research Foundation, The Netherlands, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
search

1. Study Identification

Unique Protocol Identification Number
NCT03808051
Brief Title
Aeration, Breathing, Clamping Study 3
Acronym
ABC3
Official Title
Physiological-based Cord Clamping in Very Preterm Infants: a Multicentre Randomised Controlled Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
January 25, 2019 (Actual)
Primary Completion Date
May 15, 2023 (Anticipated)
Study Completion Date
May 15, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Leiden University Medical Center
Collaborators
Erasmus Medical Center, Medical Research Foundation, The Netherlands, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Delayed cord clamping (DCC) in preterm infants results in a decrease in mortality and a trend towards fewer intraventricular haemorrhages. However, preterm infants needing immediate interventions for stabilisation or resuscitation were generally clamped immediately and excluded from trials, while these infants might benefit the most of DCC. Studies in preterm lambs demonstrated that delaying cord clamping beyond ventilation onset resulted in more stable hemodynamic transition. This approach was called 'physiological-based cord clamping' (PBCC). The hypothesis of this study is that PBCC in preterm infants at birth will lead to an increase in intact survival when compared to standard care. This study is a multicentre randomised controlled, parallel design, superiority trial, including preterm infants less than 30 weeks of gestation. The intervention is PBCC: stabilisation of the infant with the umbilical cord intact and only clamp the cord when the infant is stable. Stable is defined as the establishment of heart rate greater than 100 bpm and oxygen saturation above 85% while using supplemental oxygen lower than 40%. In the control group cord clamping will be performed time-based: infants are clamped first (at 30-60 seconds if the clinical condition allows) and then moved to the resuscitation table for further stabilisation. The primary outcome will be intact survival at NICU discharge, defined as survival without cerebral injury (intraventricular haemorrhage ≥ grade 2 and/or periventricular leukomalacia ≥ grade 2 and/or periventricular venous infarction) and/or necrotizing enterocolitis (Bell stage ≥ 2).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Preterm Infant, Birth, Preterm
Keywords
Preterm infant, Cord clamping, Resuscitation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
689 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Physiological-based cord clamping
Arm Type
Experimental
Arm Description
Stabilisation of the infant is performed while the cord is intact and the cord will be clamped after the infant is cardiopulmonary stable. Stable is defined as the establishment of heart rate greater than 100 bpm and oxygen saturation above 85% while using supplemental oxygen lower than 40%. The maximum cord clamping time is 10 minutes and prior to cord clamping a trial of weaning from PPV to CPAP is performed. With the exception that the infant is stabilised close to the mother and the cord is clamped later, the infant will receive standard resuscitation interventions.
Arm Title
Time-based cord clamping
Arm Type
Active Comparator
Arm Description
Infants are clamped first and then moved to the standard resuscitation table for further treatment and intervention needed for cardiopulmonary stabilisation. Clamping is time based and performed immediately or delayed at 30-60 seconds, depending on the clinical condition of the infant. Uterotonic drugs are administered immediately after cord clamping.
Intervention Type
Procedure
Intervention Name(s)
Physiological-based cord clamping
Intervention Description
See Arm description.
Intervention Type
Procedure
Intervention Name(s)
Time-based cord clamping
Intervention Description
See Arm description.
Primary Outcome Measure Information:
Title
Intact survival at NICU discharge
Description
Intact survival is defined as survival without major cerebral injury (IVH ≥ grade 2 and/or PVL ≥ grade 2 and/or periventricular venous infarction) and/or NEC ≥ Bell stage 2.
Time Frame
From date of randomization until the date of death or the date of NICU discharge, whichever came first, assessed up to 24 weeks.
Secondary Outcome Measure Information:
Title
Rate of treatment failure
Description
Treatment failure defined as the number of participants in which abortion of prescribed procedure (intervention or control) occurred and the reasons for abortion.
Time Frame
From birth until one hour of age.
Title
Short-term neonatal outcomes
Description
Incidence of prematurity related morbidities during hospital stay.
Time Frame
From date of randomization until the date of death or the date of NICU discharge, whichever came first, assessed up to 24 weeks.
Title
Short-term maternal outcomes
Description
Incidence of postpartum haemorrhage (> 1000 ml) and surgical site infection after caesarean section.
Time Frame
From date of randomization until five days after intervention.
Title
Neurodevelopmental outcome (Cognitive) at 2 years corrected age
Description
Neurodevelopmental outcome assessed at 2 years corrected age by the standardized Bayley Scales of Infant Development III (BSID-III-NL), resulting in the Mental Developmental Index. A score of less than 85 (1 SD below the mean of 100) is considered as delayed development.
Time Frame
Assesment at two years corrected age.
Title
Neurodevelopmental outcome (Motor) at 2 years corrected age
Description
Neurodevelopmental outcome assessed at 2 years corrected age by the standardized Bayley Scales of Infant Development III (BSID-III-NL), resulting in the Performance Developmental Index. A score of less than 85 (1 SD below the mean of 100) is considered as delayed development.
Time Frame
Assesment at two years corrected age.
Title
Functional outcome at 2 years corrected age
Description
The proportion of participants with cerebral palsy, the proportion of participants with hearing loss requiring hearing aids and the proportion of participants with blindness.
Time Frame
Assesment at two years corrected age.
Other Pre-specified Outcome Measures:
Title
Parental perception and appreciation of stabilisation at birth
Description
Questionnaire sent to parents concerning the perception and appreciation of the approach during birth and the perinatal stabilisation of the infant.
Time Frame
Sent within 1 week after birth.

10. Eligibility

Sex
All
Maximum Age & Unit of Time
29 Weeks
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Infants born at a gestational age below 30 weeks in a participating centre. Parental consent (see 9.2). Exclusion Criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: Significant congenital malformations influencing cardiopulmonary transition. Signs of acute placental abruption. Anterior placenta praevia or invasive placentation (accreta/percreta). Birth by emergency caesarean section (ordered to be executed within 15 minutes). Maternal general anaesthesia during caesarean section. Twin gestation with signs of Twin Transfusion Syndrome or Twin Anaemia Polycythemia Syndrome not treated with fetoscopic laser treatment. Multiple pregnancy > 2 (triplets or higher order). Decision documented to give palliative neonatal care. In case of twin delivery by caesarean section it is not possible to perform PBCC in both infants. Both infants will be included: the first infant will receive standard treatment and the second infant will be randomised to either PBCC or standard treatment.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Arjan B Te Pas, Prof
Organizational Affiliation
Leiden University Medical Centre
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Ronny Knol, MD
Organizational Affiliation
Erasmus Medical Centre Rotterdam
Official's Role
Principal Investigator
Facility Information:
Facility Name
Amsterdam University Medical Centre, location AMC
City
Amsterdam
Country
Netherlands
Facility Name
Amsterdam University Medical Centre, location VU
City
Amsterdam
Country
Netherlands
Facility Name
University Medical Centre Groningen
City
Groningen
Country
Netherlands
Facility Name
Leiden University Medical Centre
City
Leiden
Country
Netherlands
Facility Name
Maastricht University Medical Centre
City
Maastricht
Country
Netherlands
Facility Name
Radboud University Medical Centre
City
Nijmegen
Country
Netherlands
Facility Name
Erasmus Medical Centre - Sophia Children's Hospital
City
Rotterdam
Country
Netherlands
Facility Name
University Medical Centre Utrecht
City
Utrecht
Country
Netherlands
Facility Name
Maxima Medical Centre
City
Veldhoven
Country
Netherlands
Facility Name
Isala Clinics Zwolle
City
Zwolle
Country
Netherlands

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
36183143
Citation
Knol R, Brouwer E, van den Akker T, DeKoninck PLJ, Lopriore E, Onland W, Vermeulen MJ, van den Akker-van Marle ME, van Bodegom-Vos L, de Boode WP, van Kaam AH, Reiss IKM, Polglase GR, Hutten GJ, Prins SA, Mulder EEM, Hulzebos CV, van Sambeeck SJ, van der Putten ME, Zonnenberg IA, Hooper SB, Te Pas AB. Physiological-based cord clamping in very preterm infants: the Aeration, Breathing, Clamping 3 (ABC3) trial-study protocol for a multicentre randomised controlled trial. Trials. 2022 Oct 1;23(1):838. doi: 10.1186/s13063-022-06789-6.
Results Reference
derived

Learn more about this trial

Aeration, Breathing, Clamping Study 3

We'll reach out to this number within 24 hrs